1. OS4.3 The BReMen trial: Patients with benign meningioma - is rehabilitation really necessary?. (19th September 2018) Authors: Kessler, A F; Krause, K; Al-Shameri, B; Weiland, J; Linsenmann, T; Ernestus, R; Hagemann, C; Löhr, M; Jentschke, E Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P01.050 Circulating MACC1 transcript plasma levels in glioblastoma patients segregate together with prognostic markers and treatment response. (19th September 2018) Authors: Hagemann, C; Neuhaus, N; Dahlmann, M; Kessler, A F; Kobelt, D; Herrmann, P; Eyrich, M; Freitag, B; Freitag, B; Linsenmann, T; Monoranu, C M; Ernestus, R; Löhr, M; Stein, U Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P04.33 Effects of Tumor Treating Fields (TTFields) on blood brain barrier (BBB) permeability. (19th September 2018) Authors: Kessler, A F; Schaeffer, C; Burek, M; Ruschig, U; Ernestus, R; Löhr, M; Förster, C; Hagemann, C Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P10.01.A Reversible blood-brain barrier (BBB) disruption by Tumor Treating Fields (TTFields) in a human 3Din vitro model. (5th September 2022) Authors: Salvador, E; Kessler, A F; Köppl, T; Schönhärl, S; Burek, M; Tempel Brami, C; Voloshin, T; Giladi, M; Ernestus, R; Löhr, M; Förster, C; Hagemann, C Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗